1. Home
  2. QNTM vs POLA Comparison

QNTM vs POLA Comparison

Compare QNTM & POLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNTM
  • POLA
  • Stock Information
  • Founded
  • QNTM 1998
  • POLA 1979
  • Country
  • QNTM Canada
  • POLA United States
  • Employees
  • QNTM N/A
  • POLA N/A
  • Industry
  • QNTM
  • POLA Industrial Machinery/Components
  • Sector
  • QNTM
  • POLA Miscellaneous
  • Exchange
  • QNTM NYSE
  • POLA Nasdaq
  • Market Cap
  • QNTM 9.1M
  • POLA 8.3M
  • IPO Year
  • QNTM N/A
  • POLA 2016
  • Fundamental
  • Price
  • QNTM $6.23
  • POLA $2.90
  • Analyst Decision
  • QNTM
  • POLA
  • Analyst Count
  • QNTM 0
  • POLA 0
  • Target Price
  • QNTM N/A
  • POLA N/A
  • AVG Volume (30 Days)
  • QNTM 7.0M
  • POLA 12.2K
  • Earning Date
  • QNTM 03-31-2025
  • POLA 11-14-2024
  • Dividend Yield
  • QNTM N/A
  • POLA N/A
  • EPS Growth
  • QNTM N/A
  • POLA N/A
  • EPS
  • QNTM N/A
  • POLA N/A
  • Revenue
  • QNTM N/A
  • POLA $14,953,000.00
  • Revenue This Year
  • QNTM N/A
  • POLA $6.72
  • Revenue Next Year
  • QNTM N/A
  • POLA N/A
  • P/E Ratio
  • QNTM N/A
  • POLA N/A
  • Revenue Growth
  • QNTM N/A
  • POLA N/A
  • 52 Week Low
  • QNTM $2.70
  • POLA $2.31
  • 52 Week High
  • QNTM $70.20
  • POLA $4.90
  • Technical
  • Relative Strength Index (RSI)
  • QNTM 46.46
  • POLA 48.10
  • Support Level
  • QNTM $10.68
  • POLA $2.76
  • Resistance Level
  • QNTM $12.44
  • POLA $3.19
  • Average True Range (ATR)
  • QNTM 2.41
  • POLA 0.14
  • MACD
  • QNTM -0.42
  • POLA 0.02
  • Stochastic Oscillator
  • QNTM 21.66
  • POLA 35.56

About QNTM QUANTUM BIOPHARMA LTD

Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.

About POLA Polar Power Inc.

Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications primarily in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, Back-up DC generators, hybrid power systems, Li-Ion battery systems, and Marine DC generators. The Companie's geographical presence is in the United States, Canada, Mexico, South Pacific Islands, Japan, Europe and Middle East and Other Asia Pacific countries.

Share on Social Networks: